Related Experiment Video
Updated: May 30, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
The correlation between vagus nerve stimulation efficacy and partial onset epilepsies
Ahmet Z Burakgazi1, Evren Burakgazi-Dalkilic, Anthony J Caputy
1Department of Neurology, George Washington University, Washington, District of Columbia 20037, USA. drburakgazi@yahoo.com
Summary
Vagus nerve stimulation (VNS) shows higher efficacy in treating frontal lobe epilepsy compared to temporal lobe epilepsy (TLE). This finding suggests seizure origin influences VNS treatment outcomes in epilepsy patients.
Area of Science:
- Neurology
- Epileptology
- Neurosurgery
Background:
- Epilepsy is a chronic neurological disorder characterized by recurrent seizures.
- Vagus nerve stimulation (VNS) is an established treatment for medically intractable epilepsy.
- The efficacy of VNS may vary depending on the underlying epilepsy characteristics.
Purpose of the Study:
- To investigate the relationship between the effectiveness of VNS and the specific brain regions where partial seizures originate.
- To determine if the origin of partial seizures influences the success rate of VNS therapy.
Main Methods:
- Retrospective analysis of 46 epilepsy patients who underwent VNS implantation between 1999 and 2005.
- Patients were classified based on seizure origin (frontal vs. temporal lobe epilepsy).
- Clinical outcomes were assessed using the Engel classification, with Engel I-III considered a satisfactory outcome.
Main Results:
- A satisfactory outcome (Engel II, III) was achieved in 41.3% of patients.
- VNS demonstrated significantly higher efficacy in patients with frontal lobe epilepsy (65% satisfactory outcome) compared to temporal lobe epilepsy (15% satisfactory outcome).
- The difference in VNS outcomes between frontal and temporal lobe epilepsy was statistically significant (P = 0.004).
Conclusions:
- Vagus nerve stimulation is more effective for epilepsy originating in the frontal lobe than in the temporal lobe.
- Seizure origin is a critical factor influencing VNS efficacy.
- Further research is needed to confirm these findings and explore the correlation between epilepsy types and VNS outcomes.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:24Local Anesthetics: Differential Sensitivity of Nerve Fibers
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...